|Email Newsletters from Pharmaceutical Technology and Pharmaceutical Technology Europe|
Providing the latest business, scientific, and regulatory news for the pharmaceutical and biotech industries.
News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.
Industry Briefs: Apr. 30, 2012
AMRI has launched Smartsourcing sourcing options for its contract manufacturing and research services. Read More
AstraZeneca and The Medicines Company have entered into a global development and commercialization pact and have agreed to copromote Brilinta (ticagrelor), for treating acute ischaemic heart disease, in the United States. Read More
Baxter International has completed its purchase of Sigma International. Read More
Cetero Research has reached a final resolution with FDA over studies the company conducted in its Houston, Texas, bioanalytical laboratory between Apr. 1, 2005 through June 15, 2010. Read More
Covance and BML are expanding the companies’ jointly owned clinical-trial laboratory in Japan. Read More
GlaxoSmithKline and the University of Nottingham are collaborating to create a Center of Excellence for sustainable chemistry. Read More
Penn Pharma has invested in additional clinical and commercial packing capabilities. Read More
Teva has settled its patent-infringement litigation with Mylan in regards to Teva’s wakefulness product Nuvigil (armodafinil). Read More
Therapure has opened a custom biologics manufacturing facility. Read More
AMRI has appointed Saravanakumar Dhakshinamoorthy as director of in vitro biology. Dhakshinamoorthy will report to Takeshi Yura, senior director of AMRI’s Singapore division. Read More
Watson Pharmaceuticals has announced changes in the company’s senior leadership. Read More